£141.67

It has never been this cheap. We have no record of a lower price.

£142 today · cheaper than every other day in the last 3 months

Humana 5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£141.73 £141.66 £141.68 £141.69 £141.71 £141.72 £141.74 25 July 2026 09 August 2026 24 August 2026 08 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 1 price levels

Days at Price
62 days 0 16 31 47 62 £142 Days at Price

Price Analysis

Most common price: £142 (62 days, 100.0%)

Price range: £142 - £142

Price levels: 1 different prices over 62 days

Description

Part of Springer’s “The Receptors,” series, this text is the first ever overview on the research of 5-HT2c receptors. 5-HT2c receptor research has been productive for twenty-five years, but recent years have seen an extraordinary increase in both amount produced and insight gained. 5-HT2c is a prominent central serotonin receptor subtype widely expressed within the central and the peripheral nervous system and is thought to play a key role in the regulation of numerous behaviors. This text covers the molecular, cellular, anatomical, biochemical and behavioral aspects of this receptor, highlighting its distinctive regulatory properties and the emerging functional significance of constitutive activity and RNA-editing in vivo. It also investigates the receptors’ therapeutic potential in many diseases, treated individually in separate chapters, including depression, drug abuse, schizophrenia, eating disorders, Parkinson’s disease, Prader-Willi Syndrome, Alzheimer’s disease and epilepsy.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Serotonin Receptors in Neurobiology (Frontiers in Neuroscience)
97% match

Serotonin Receptors in Neurobiology (Frontiers in Neuroscience)

CRC Press

£180.50 24 Sep 2026
Serotonin: From Cell Biology to Pharmacology and Therapeutics: 5 (Medical Science Symposia Series, 5)
97% match

Serotonin: From Cell Biology to Pharmacology and Therapeutics: 5 (Medical Science Symposia Series, 5)

Springer

£169.84 09 Sep 2026
Academic Press Handbook of Behavioral Neurobiology of Serotonin
97% match

Academic Press Handbook of Behavioral Neurobiology of Serotonin

Elsevier

£135.00 01 Oct 2026
Neuropsychopharmacology: 64 (Journal of Neural Transmission. Supplementa, 64)
97% match

Neuropsychopharmacology: 64 (Journal of Neural Transmission. Supplementa, 64)

Springer

£82.00 18 Sep 2026
Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172
96% match

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172

Elsevier

£182.59 25 Sep 2026
Brain Function and Psychotropic Drugs (Oxford Medical Publications)
96% match

Brain Function and Psychotropic Drugs (Oxford Medical Publications)

Oxford University Press

£59.00 10 Sep 2026
Dopamine Receptor Technologies: 96 (Neuromethods, 96)
96% match

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

Humana

£79.93 01 Oct 2026
Central Serotonin Receptors and Psychotropic Drugs (Frontiers in Pharmacology & Therapeutics)
96% match

Central Serotonin Receptors and Psychotropic Drugs (Frontiers in Pharmacology & Therapeutics)

Wiley

Price unavailable
Serotonin Receptor Technologies: 95 (Neuromethods, 95)
96% match

Serotonin Receptor Technologies: 95 (Neuromethods, 95)

Humana

£69.76 23 Sep 2026
Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years Of Research: 60 (Current Topics in Behavioral Neurosciences, 60)
96% match

Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years Of Research: 60 (Current Topics in Behavioral Neurosciences, 60)

Springer

£83.07 30 Sep 2026
Advances in Neuropharmacology: Drugs and Therapeutics
96% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£77.00 26 Sep 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
96% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Elsevier

£105.39 12 Sep 2026
The Serotonin System: History, Neuropharmacology, and Pathology
96% match

The Serotonin System: History, Neuropharmacology, and Pathology

Elsevier

£104.49 26 Sep 2026
Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)
96% match

Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)

Springer

£109.64 01 Oct 2026
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
96% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£165.06 03 Sep 2026
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
96% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£141.86 02 Oct 2026
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
96% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£81.06 26 Sep 2026
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
96% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£104.34 17 Sep 2026
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)
96% match

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Elsevier

£129.00 01 Oct 2026
Animal Models in Psychiatry, II: 19 (Neuromethods, 19)
96% match

Animal Models in Psychiatry, II: 19 (Neuromethods, 19)

Humana

£27.58 02 Oct 2026
Molecular Psychiatry
96% match

Molecular Psychiatry

MDPI AG

£61.89 13 Sep 2026